Exelixis Inc Payments for (Proceeds from) Businesses and Interest in Affiliates
Exelixis Inc (EXEL) reported Payments for (Proceeds from) Businesses and Interest in Affiliates of $2.25 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates · last filed 2012-02-22
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2011-12-31 was $44.00K, a 89.00% decline year-over-year.
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2011-09-30 was $2.21M.
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2010-12-31 was $400.00K.
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2010-09-30 was $0.00.
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for fiscal 2011 was $2.25M, a 72.50% decline from fiscal 2010.
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for fiscal 2010 was $8.20M, a 299.46% increase from fiscal 2009.
- Exelixis Inc payments for (proceeds from) businesses and interest in affiliates for fiscal 2009 was $2.05M.
| Period end | Payments for (Proceeds from) Businesses and Interest in Affiliates 3 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 6 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 9 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 12 month |
|---|---|---|---|---|
| 2011-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $2.25M derived: sum of 2 quarters · filed 2012-02-22 | $2.25M 10-K · filed 2012-02-22 | |
| 2011-09-30 | $2.21M 10-Q · filed 2011-10-27 | $2.21M 10-Q · filed 2011-10-27 | ||
| 2010-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $400.00K derived: sum of 2 quarters · filed 2012-02-22 | $3.70M derived: sum of 3 quarters · filed 2012-02-22 | $8.20M 10-K · filed 2012-02-22 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $3.30M derived: sum of 2 quarters · filed 2011-10-27 | $7.80M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $3.30M 10-Q · filed 2011-08-04 | $7.80M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | $2.05M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |